Advertisement

Pharmacy World & Science

, Volume 32, Issue 5, pp 562–565 | Cite as

GPs’ views on patient drug use and the pharmacist’s role in DRP management

  • Tommy WesterlundEmail author
  • Jan-Olof Brånstad
Short Research Report

Abstract

Objective The aim of this study was to examine general practitioners’ (GPs’) views on (1) patients’ drug-related problems (DRPs) and noncompliance and (2) the role of pharmacy practitioners in DRP management. Method A brief questionnaire was designed and distributed to 224 GPs in Sweden. Results Totally 152 GPs responded (68%). Most felt that pharmacy practitioners could improve patients’ drug use by identifying DRPs. A majority of the GPs also found presentations and analyses of their local pharmacies’ DRP documentation valuable. According to the GPs’ experiences, adverse drug effects and therapy failure were the most salient problems in patients’ drug use. Half of the doctors believed that 50–75% of their patients were compliant with their prescribed drug treatments. A majority of the GPs found a 75–95% degree of compliance acceptable. Conclusion The surveyed GPs demonstrated very positive attitudes towards the role of pharmacy practitioners in improving patients’ drug use and managing DRPs. The GPs realised that many patients were not compliant with their prescribed drug treatments and accepted an imperfect compliance.

Keywords

Collaboration Community pharmacy Compliance Drug-related problems General practitioner opinions Sweden 

Notes

Acknowledgments

We like to thank pharmacy student Pernilla Olsson, now a MSc(Pharm), for her skilful collection and compilation of data. Also thanks to the pharmacies for kind assistance in distributing the questionnaires, to the responding GPs for making this survey possible and to Fredrik Ax, MSc(Pharm) for general support.

Funding

The study was funded by Apoteket AB.

Conflicts of interest

None.

References

  1. 1.
    Chen TF, Crampton M, Krass I, Benrimoj SI. Collaboration between community pharmacists and GPs in innovative clinical services—a conceptual model. J Soc Adm Pharm. 1999;16:134–44.Google Scholar
  2. 2.
    Zillich AJ, Milchak JL, Carter BL, Doucette WR. Utility of a questionnaire to measure physician–pharmacist collaborative relationships. J Am Pharm Assoc (2003). 2006;46:453–8.CrossRefGoogle Scholar
  3. 3.
    Bradshaw SJ, Doucette WR. Community pharmacists as patient advocates: physician attitudes. J Am Pharm Assoc. 1998;38:598–602.Google Scholar
  4. 4.
    Ranelli PL, Biss J. Physicians’ perceptions of communication with and responsibilities of pharmacists. J Am Pharm Assoc. 2000;40:625–30.Google Scholar
  5. 5.
    World Health Organization. Adherence to long-term therapies. Evidence for action. WHO/MNC/03.01. Geneva, 2003.Google Scholar
  6. 6.
    Krigsman K, Bastholm Rahmner P, Fuchs R, Nordström-Torpenberg I, Pettersson S, Nilsson JLG. Rational use of medicine. Use of concordance to improve patient adherence. WHO Drug Inf. 2007;21(1):27–32.Google Scholar
  7. 7.
    Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41:192–9.Google Scholar
  8. 8.
    Westerlund LOT, Björk HT. Pharmaceutical care in community pharmacies: practice and research in Sweden. Ann Pharmacother. 2006;40:1162–9. Epub 30 May 2006.CrossRefPubMedGoogle Scholar
  9. 9.
    Ax F, Brånstad J-O, Westerlund T. Pharmacy counselling models—a means to improve patient drug use. J Clin Pharm Ther. Epub 30 Mar 2010. doi: 10.1111/j.1365-2710.2009.01138.x.
  10. 10.
    Márquez Contreras E, de la Figuera von Wichmann M, Roig Ponsa L, Naval Chamosa J. El cumplimiento terapéutico en la hypertensión arterial en España, según la opinión de los médicos de familia. Proyecto Cumplex. [Compliance with hypertension therapy in Spain, according to the views of family doctors. Complex project.]. Aten Primaria. 2007;39:417–23. (in Spanish).CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.Research and DevelopmentApoteket ABHelsingborgSweden
  2. 2.Apoteket ABStockholmSweden
  3. 3.Sahlgrenska Academy, Institute of Medicine, Department of Public Health and Community Medicine, Unit of Social MedicineUniversity of GothenburgGöteborgSweden

Personalised recommendations